Pharmeasy Share Price

PharmEasy Unlisted Share Price & API Holding Ltd. - Company Overview   

API Holdings Limited formerly known as API Holdings Private Limited is an unlisted public limited company, incorporated on 31st March 2019.

API Holdings Limited is India's largest digital healthcare platform in terms of the gross merchandise value (GMV) of products and services sold.

The Company is engaged in diversified businesses primarily trading pharmaceutical and cosmetic goods, licensing of internet portals or mobile applications related to sales and distribution of pharmaceutical and cosmetic goods, diagnostic services, teleconsulting, etc.

API Holdings Ltd, the parent company of online pharmacy and health tech platform PharmEasy, which recently withdrew its IPO due to "market conditions and external factors”, recorded a larger loss for FY22 than the previous year. Pharmeasy share price has grown from a distributor of medicinal products to a fully integrated, digital healthcare platform that offers teleconsultation, medical equipment, and pharmaceuticals.

PharmEasy Unlisted Share Price, API Holding Pre IPO Stock Details as of March 31, 2024

API Holding Limited (PharmEasy) Incorporation Details

PharmEasy Board of Directors

Mr. Aditya Puri, Chairman, Non-Executive Director

Mr. Deepak Vaidya, Independent, Non-Executive Director

Mr. Ankur Thadani, Non-Executive Director

Mr. Ashutosh Sharma, Non-Executive Director

Ms. Vineeta Rai, Independent, Non-Executive Director

Dr. Jaydeep Tank, Independent, Non-Executive Director

Mr. Subramaniam Somasundaram, Independent, Non-Executive Director

Mr. Siddharth Shah, MD, and CEO

Mr. Harsh Parekh, Whole-time Director

Mr. Dharmil Sheth, Whole-time Director

PharmEasy Subsidiary & Associate Companies,

PharmEasy Industry Outlook

According to a Red Seer Report, the company has a target addressable market of Rs. 10.4 trillion ($139 billion) as of 2020, which corresponds to the size of the entire Indian Healthcare market in 2020. The target addressable market is expected to grow at a 14% CAGR to reach $20 trillion ($266 billion) by 2025.

Online pharmacy-led play: Online pharmacies, consisting of at-home delivery of prescription medicines, covered 63% of the market pre-COVID in 2019 and held 55% of the market in 2020, despite the disruption in pharma supply. eOTC is the second-largest segment, constituting doorstep delivery of generic medicines and health products. It accounted for 26% of the market share before COVID, which soared to 35% in 2020, owing to the high demand for COVID-related OTC products.

Large headroom ahead: Despite the high growth, digital penetration in health (across pharma, OTC, diagnostics, and consultation) is only at 2%, indicating a very nascent stage of penetration. For example, online pharmacy penetration in India was 2.3% in 2020, significantly lower than in China (10-15%) and the United States (30-35%). 

FAQs on PharmEasy Pre IPO Shares

Q.1 Does PharmEasy have an IPO?

A.1 PharmEasy is preparing to launch its IPO.

Q.2 How do I buy PharmEasy shares?

A.2 One can buy PharmEasy shares online through our website, or investors can call us and confirm the deal with our Relationship Manager at 966999944, 7999252591, or 0731-4025544.

Q.3 Is PharmEasy a profitable company?

A.3 No, the company has not yet been profitable because PharmEasy suffered a loss of 39,924.96 million in FY 2022.

Q.4 What is Phrameasy share price today?

A.4  Pharmeasy share price used to change every day like other companies ' share prices. To find out the most recent Phrameasy share price contact us 

Q5) Buying Pharmeasy Pre IPO shares is legal in india or not ?

Ans) Yes, Buying and Selling Pharmeasy Pre IPO shares is absolutely 100 % legal in India, since the whole transaction process 

    is regulated and governed by Securities and Exchange Board of India (SEBI).

Q6) What is the duration of lock in period in the case of selling Pharmeasy Pre IPO Shares?

Ans) In the case of selling , the duration of lock in period is 6 months from the date of listing of Pharmeasy IPO  for retail investors 

Q7)What is the use of DIS in selling Pharmeasy Pre IPO Shares?

Ans) The investors are required to fill the DIS (Delivery instruction slip) and submit to their broker. The mandatory fields in 

 the DIS includes :

  a)ISIN no.of Pharmeasy Pre IPO Shares

   b)name of the pharmeasy Pre IPO Share

   c)total selling quantity of Pharmeasy Pre IPO shares

   d) DP ID and client ID 

   e) off market annexure 

 Q8) How to track news updates about Pharmeasy Pre IPO Shares?

 Ans) For tracking news updates about Pharmeasy Pre IPO shares you can simply visit our website news section https://wwipl.com/news 

     to get the latest updates about Pharmeasy Pre IPO shares.

Q9) How much time is required to credit the Pharmeasy Pre IPO Shares into the Demat Account?

  Ans) The Pharmeasy Pre IPO shares credited will be reflected in T + 1 Day in the respective clients' demat account.

Q10) What is the minimum required amount for making investments in Pharmeasy Pre IPO shares?

  Ans) The minimum required amount for investing in Pharmeasy Pre IPO Shares is 10000 Rupees.